Pharsight

Drugs that contain Bepotastine Besilate

1. Bepreve patents expiration

BEPREVE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8877168 BAUSCH AND LOMB INC Aqueous liquid preparations and light-stabilized aqueous liquid preparations
Jul, 2023

(7 months ago)

US8784789 BAUSCH AND LOMB INC Aqueous liquid preparations and light-stabilized aqueous liquid preparations
Jan, 2025

(10 months from now)

Market Authorisation Date: 08 September, 2009

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of BEPREVE before it's drug patent expiration?
More Information on Dosage

BEPREVE family patents

Family Patents